Peter Geschek
Long only

Intrexon: A Billionaire's Dream About The Future Of Biotech

Intrexon Corp. (NYSE:XON) of Germantown, Md., began trading on the New York Stock Exchange on August 9.

The IPO was quite successful. It was oversubscribed by an estimated 15-20 percent and sold 11.5 million shares at $16 apiece, clearing about $160 million. In addition, it traded on its first day up more than 50 percent, for a new market cap of about $2 billion.

The success of the IPO made founder Randal Kirk even wealthier. He owns 62 million shares, more than 60 percent of the company. His total holding in Intrexon has overnight gone to over $1.5 billion, which is nice for a man who already had $2.4 billion in estimated net worth.

The performance...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details